WPHM 株価推移チャート
WPHM 収入
Winston Pharmaceuticals Inc
$0
0%
$0
終値： May 07, 16:00:00 GMT-4
$0
0%
$0
アフターマーケット：May 07, 20:00:00 GMT-4
戻る
Winston Pharmaceuticals Inc (WPHM) 収入
Earnings FAQ
WPHMの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Winston Pharmaceuticals Inc WPHMの前四半期の収益はどうでしたか？
Winston Pharmaceuticals Incの収益見積もりはいくらですか？
Winston Pharmaceuticals Incの収益品質スコアはどれくらいですか？
Winston Pharmaceuticals Incはいつ収益を報告しますか？
Winston Pharmaceuticals Incの予想収益はいくらですか？
Winston Pharmaceuticals Incは収益予想を上回りましたか？
主要データ
前終値
$0.0001
始値
$0.0001
当日レンジ
$0.0001 - $0.0001
52週レンジ
$0 - $0.0001
取引高
16.1K
平均取引高
5.5K
配当利回り
--
1株当たり利益(TTM)
-0.04
時価総額
$7.7K
WPHMとは何ですか？
Winston Pharmaceuticals, Inc. operates as a pharmaceutical company which engages in the discovery and development of products for pain management. The company is headquartered in Vernon Hills, Illinois and currently employs 9 full-time employees. The company went IPO on 2006-02-23. The firm discovers, develops and commercializes therapeutics for managing and alleviating pain. The firm's late stage candidates include products for the treatment of episodic cluster headache, chronic migraine headache, osteoarthritis, rheumatoid arthritis, neuropathic pain, and pain and inflammation in inflammatory bowel disease. The firm is developing Civamide, which is a transient receptor potential channels vanilloid-1 (TRPV-1) modulator in different dosage forms for several different pain indications. The firm's other products are under development for the treatment of headache and neuropathic and rheumatological pain.
